Aussie device to make U.S. debut


Aussie device O2Vent to make U.S. debutAustralian medical device manufacturer Oventus Medical is set to put snoring to bed in the U.S. with its 3D-printed snoring and apnoea solution. The O2Vent is a titanium mouthguard that may help the 37 million Americans who suffer from snoring and the roughly 12–18 million with sleep apnoea.

“The most common treatment for sleep disordered breathing is Continuous Positive Airway Pressure (CPAP) which requires patients to wear a face or nasal mask during sleep. The mask, connected to a pump, provides a positive flow of air into the nasal passages in order to keep the airway open,” said Oventus in a statement.

The O2Vent is a mouthguard rather than a mask patients have to fit over their face, and is designed to be more comfortable and reduce “dry throat, sore throat, dry nose, irritation to the face from the mask, claustrophobia or nasal obstruction,” the company said.

The company’s statement said they had “devised an oral mouthguard that incorporated an airway that directs air to the back of the throat to increase airflow and bypass obstructions of the nose, tongue and soft palate. The device, a 3D-printed titanium mouthguard, is custom-made to fit individual sufferers rather than a one size fits all approach.”

The Australian device, developed by Oventus’ founder Chris Hart, has been cleared by the FDA and will make its U.S. debut at two Denver conferences: the American Academy of Dental Sleep Medicine’s 25th Annual Meeting and at Sleep 2016.

“The recent clinical trial data strongly showed that the O2Vent significantly reduced snoring and sleep apnoea in most patients studied, even in those who historically did not benefit from other treatments due to chronic nasal obstruction,” said Hart of the device. “The trial also demonstrated that the device improves oxygen levels in most patients. A greater number of patients who snore or who suffer from mild to moderate sleep apnoea but who are CPAP intolerant, now have an alternative treatment option available.”


Please enter your comment!
Please enter your name here